These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2476302)

  • 1. Serum enzyme changes after ERCP.
    Tulassay Z
    Endoscopy; 1989 Jul; 21(4):197-8. PubMed ID: 2476302
    [No Abstract]   [Full Text] [Related]  

  • 2. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
    O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT
    Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of iopamidol, a non-ionic contrast medium, in retrograde cholangiopancreatography: a comparative evaluation.
    Camellini U; Marconi G; Abelli P; Cocchi S; Cerutti R
    Rays; 1985; 10(1):53-9. PubMed ID: 3843636
    [No Abstract]   [Full Text] [Related]  

  • 4. The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol.
    Mäkelä P; Dean PB
    Eur J Radiol; 1986 Nov; 6(4):303-4. PubMed ID: 2431908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum amylase, lipase and trypsin after retrograde cholangiopancreatography].
    Lesi C; Franceschi F; Scandellari A; Cucci AM; Ruscelli C; Piovesan M; Matacena C; Peppi M; Zoni L; Malaguti P
    Gastroenterol Clin Biol; 1984 Feb; 8(2):196-8. PubMed ID: 6199253
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes.
    Doppl WE; Weber HP; Temme H; Klör HU; Federlin K
    Eur J Med Res; 1996 Mar; 1(6):303-11. PubMed ID: 9367944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
    Gottlieb K; Sherman S; Pezzi J; Esber E; Lehman GA
    Am J Gastroenterol; 1996 Aug; 91(8):1553-7. PubMed ID: 8759660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
    Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU
    Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCP and biliary endoscopic sphincterotomy-induced pancreatitis.
    Gottlieb K; Sherman S
    Gastrointest Endosc Clin N Am; 1998 Jan; 8(1):87-114. PubMed ID: 9405753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
    Conn M; Goldenberg A; Concepcion L; Mandeli J
    Am J Gastroenterol; 1991 Aug; 86(8):1011-4. PubMed ID: 1713406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Visotrast (R) and bilirubin on lipase and alpha-amylase activities of pancreatic secretions].
    Winnefeld K; Bosseckert H; Schmidt R; Treff E; Koppe P; Schröder H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):302-6. PubMed ID: 3879215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, prospective study comparing two contrast media in ERCP.
    Cunliffe WJ; Cobden I; Lavelle MI; Lendrum R; Tait NP; Venables CW
    Endoscopy; 1987 Sep; 19(5):201-2. PubMed ID: 3678161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can somatostatin prevent injection pancreatitis after ERCP?
    Persson B; Slezak P; Efendic S; Häggmark A
    Hepatogastroenterology; 1992 Jun; 39(3):259-61. PubMed ID: 1380475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of pirenzepine on lipase levels after endoscopic retrograde cholangio-pancreaticography].
    Kratochvil P; Brandstätter G; Zenker G; Stupnicki G
    Arzneimittelforschung; 1986 Jul; 36(7):1142-3. PubMed ID: 3768085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
    JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperamylasaemia and metabolic abnormalities following endoscopic retrograde cholangiopancreatography.
    Tulassay Z
    Pancreas; 1987; 2(3):362. PubMed ID: 2442748
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity of ultrasonography in the demonstration of common bile duct stones and its ranking in comparison with intravenous cholangiography and endoscopic retrograde cholangiopancreatography.
    Myllylä V; Päivänsalo M; Pyhtinen J; Kairaluoma MI; Niemelä S
    Rofo; 1984 Aug; 141(2):192-4. PubMed ID: 6431543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of salmon calcitonin on pancreatic enzymes and hormones before and after retrograde cholangiopancreatography].
    Ohnhaus EE; Witzel L; Halter F; Stauffacher W
    Schweiz Med Wochenschr; 1981 May; 111(21):750-4. PubMed ID: 6166982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.